October 2, 2023

Prechter Program Announced as Inaugural Site for the BD² Integrated Network

BD²: Breakthrough Discoveries for Thriving with Bipolar Disorder has announced the University of Michigan  as one of the inaugural institutions that will launch the groundbreaking BD² Integrated Network. 

BD²’s Integrated Network Site Leads

The Heinz C. Prechter Bipolar Research Program at the University of Michigan has been named as one of the first six institutions that will launch the BD² Integrated Network with BD²: Breakthrough Discoveries for Thriving with Bipolar Disorder. Along with Brigham and Women’s Hospital-McLean Hospital, University of California Los Angeles, Johns Hopkins University, Mayo Clinic, UTHealth Houston, the Prechter Program at the University of Michigan will work in partnership with clinicians, researchers, and lived experience individuals to expand knowledge of bipolar disorder while accelerating the translation of that knowledge into clinical care. Over the next five years, the BD² Integrated Network will engage 4,000 people living with bipolar disorder as part of a longitudinal cohort study.

Prechter Program Associate Director, Kelly Ryan, Ph.D. is the site lead for the University of Michigan. “We are honored to be part of BD²’s Integrated Network, as one of the inaugural sites that is focused on advancing research and care for bipolar disorder. It will be a transformative network engaging clinicians, scientists, and people with bipolar disorder on a global scale. We hope to take what we learn through longitudinal research and quickly create and test new treatments to improve clinical care.”

Learn more about this groundbreaking partnership and how these site will work to improve the wellbeing of those living with bipolar disorder here.